SCHEMBL97180

SCHEMBL97180

CCCCCN([C]=O)CCCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 4/20 0.43
TSHR P16473 2/20 0.37
THRB P10828 1/20 0.37
ALDH1A1 P00352 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
ADH1C P00326 2/20 0.34
ADH1A P07327 2/20 0.34
ADH4 P08319 2/20 0.34
S1PR2 O95136 1/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
S1PR5 Q9H228 1/20 0.34
KDM5A P29375 4/20 0.33
KDM4C Q9H3R0 3/20 0.33
EPHX1 P07099 1/20 0.33
KDM5C P41229 1/20 0.33
KDM5B Q9UGL1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95388 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL271667 0.97 DNM1 (0.42) DNM1TSHRTHRBALDH1A1CA12
SCHEMBL5469943 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL11667597 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL102599 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL5479568 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL276870 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL276847 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL5480820 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL270649 0.97 DNM1 (0.48) DNM1TSHRTHRBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171515-A1 CYTOCHROME P450 INHIBITORS AND USES THEREOF ANGION BIOMEDICA CORP. 2021-06-10 US claimed
EP-3063228-B1 DISPERSE DYES, THEIR PREPARATION AND THEIR USE DYSTAR COLOURS DISTRIB GMBH (DE) 2020-04-01 EP claimed
US-20180148438-A1 CYTOCHROME P450 INHIBITORS AND USES THEREOF ANGION BIOMEDICA CORP (US) 2018-05-31 US claimed
US-20170266191-A1 Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor ACERTA PHARMA BV (NL) 2017-09-21 US claimed
US-9745474-B2 Acid dyes, process for the production thereof and their use DYSTAR COLOURS DISTRIBUTION GMBH (DE) 2017-08-29 US claimed
EP-2168968-B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS LLC (US) 2017-08-23 EP claimed
EP-2861670-B1 METAL FREE REACTIVE DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE DYSTAR COLOURS DISTRIB GMBH (DE) 2017-08-16 EP claimed
US-9725597-B2 Acid dyes, process for the production thereof and their use DYSTAR COLOURS DISTRIBUTION GMBH (DE) 2017-08-08 US claimed
EP-3063231-B1 ACID DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE DYSTAR COLOURS DISTRIB GMBH (DE) 2017-05-17 EP claimed
EP-3063232-B1 ACID DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE DYSTAR COLOURS DISTRIB GMBH (DE) 2017-05-17 EP claimed
US-20040236109-A1 Tetrahydroquinoline derivatives MERCK SHARP & DOHME B.V. (NL) 2004-11-25 US claimed
JP-2002501515-A 2002-01-15 JP claimed
US-6313344-B1 PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-11-06 US claimed
EP-0984923-A1 O-BENZYL OXIME ETHERS AND THEIR USE AS PESTICIDES Novartis AG (CH) 2000-03-15 EP claimed
EP-0527049-B1 Quinophthalone compound MITSUI CHEMICALS INC (JP) 1998-12-23 EP claimed
WO-1998054125-A1 O-BENZYL OXIME ETHERS AND THEIR USE AS PESTICIDES NOVARTIS AG (CH) 1998-12-03 WO claimed
EP-0416810-B1 Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates BEECHAM GROUP PLC (GB) 1995-02-08 EP claimed
EP-0416810-A2 Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates Beecham Group p.l.c. (GB) 1991-03-13 EP claimed
EP-0023045-B1 IMIDAZOLECARBOXYLIC ACID DERIVATIVES OF PENICILLINS AND CEPHALOSPORINS AJINOMOTO CO., INC. (JP) 1984-04-11 EP claimed
EP-0052842-A2 N,N-diaryl carbamoyl fluorides, process for preparing them and their use in the preparation of ureas, and the ureas obtained thereby BAYER AG (DE) 1982-06-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171515-A1 CYTOCHROME P450 INHIBITORS AND USES THEREOF CYP7A1, CYP2E1, CYP11B1 DNM1 3220/4885TSHR 3893/4885THRB 2447/4885
US-20180148438-A1 CYTOCHROME P450 INHIBITORS AND USES THEREOF CYP7A1, CYP2E1, CYP11B1 DNM1 3220/4885TSHR 3893/4885THRB 2447/4885
US-20170266191-A1 Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor BTK, SYK, PIK3CD DNM1 1944/4885TSHR 2679/4885THRB 1700/4885
US-20040236109-A1 Tetrahydroquinoline derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AOC2, HTR3C DNM1 2276/4885TSHR 725/4885THRB 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.